Meg Tirrell

They will prescribe you something maybe, but I don't know.

I just think that's what do you do then if you have a problem?

You're not, you know, you go to the ER, I guess.

So that scares me a little.

I do think the idea of like how do these drugs work in folks who don't have weight to lose is something that's very interesting, especially as we start to look at them for things like addiction or Alzheimer's.

I mean, there's a lot of different indications where these could be used that have nothing to do with weight.

You don't want to lose weight, especially in an elderly person.

Maybe you're not trying to lose more weight.

And so I think that's very interesting.

And the companies, when you think about it for sort of these cosmetic purposes, you know, I just have a few pounds to lose.

They've really stayed away from that.

I mean, that is even though it is a huge market and probably a huge number of people who are taking these medicines, they haven't tested that.

It's just not where they are.

And so we don't really know other than the real world use of it.

But I've also been hearing from doctors, they're getting really worried about people getting too thin on these medicines.

And I even talked to one doctor who was just saying, even, you know, looking at some folks in Hollywood, I mean, looking at, you know, the modeling world, like thin seems to be having this, you know, resurgence.

This is extreme thinness.

And I think that is worrying to a lot of people.

Well, as you noted, GLP-1 is a peptide, and so it is sort of this larger molecule.

And so we can't swallow insulin, for example, because it doesn't get broken down in a way that we can metabolize it in our bodies.